🇺🇸 FDA
Patent

US 8198469

Crystalline forms of tigecycline and processes for preparation thereof

granted A61PA61P31/04

Quick answer

US patent 8198469 (Crystalline forms of tigecycline and processes for preparation thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P31/04